Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei.
Loiseau
P M
PM
Biologie et Contrĵle des Organismes Parasites, UPRES 398-IFR 75, Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France. Philippe. Loiseau@cep.u-psud.fr
Gutierrez-Rios
M T
MT
De Frutos
M I
MI
Craciunescu
D G
DG
D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009942:Organometallic Compounds / Q000737:chemistry / Q000627:therapeutic use*; D018512:Parasitemia / Q000188:drug therapy*; D010419:Pentamidine / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D015996:Survival Rate; D014344:Trypanocidal Agents / Q000737:chemistry / Q000627:therapeutic use*; D014346:Trypanosoma brucei brucei / Q000187:drug effects; D014353:Trypanosomiasis, African / Q000188:drug therapy* / Q000401:mortality
D009942:Organometallic Compounds; D014344:Trypanocidal Agents; D010419:Pentamidine